Results 161 to 170 of about 14,188 (207)

Class IIa HDACs forced degradation allows resensitization of oxaliplatin-resistant FBXW7-mutated colorectal cancer. [PDF]

Mol Oncol
Tolotto V, Gualandi N, Cortolezzis Y, Picco R, Colitti M, D'Este F, Gani M, Hancock WW, Terrosu G, Degrassi C, Agostini F, Brancolini C, Xodo LE, Di Giorgio E.   +13 more
europepmc   +1 more source

RETRACTION: HDAC4 Depletion Ameliorates IL-13-Triggered Inflammatory Response and Mucus Production in Nasal Epithelial Cells via Activation of SIRT1/NF-κB Signaling. [PDF]

Immun Inflamm Dis
europepmc   +1 more source

Focal Adhesion Kinase Promotes Calcification of Vascular Smooth Muscle Cells via Regulation of Histone Deacetylase 4 and 5. [PDF]

Arterioscler Thromb Vasc Biol
Tian W, Singh K, Kajuluri LP, Lu J, Lee S, Roh K, Nicholson CJ, Jiang W, Barnes HJ, Sato T, Boerboom S, Ostrom K, Li RH, Birchenough C, Moore E, Tattersfield H, Sigurslid HH, Mahamdeh MS, Mosquera JV, Hodonsky CJ, Johnson AL, Chou EL, Nigwekar S, Lindsay ME, Bloch DB, Lino Cardenas CL, Ichinose F, Miller CL, Wein MN, Malhotra R.   +29 more
europepmc   +1 more source

Fair and Square: Design, Synthesis and Biological Evaluations of Squaric Acid Derivatives as Novel HDAC8 Inhibitors. [PDF]

ChemMedChem
Long N, Meyer-Almes FJ, Kopranovic A, Wren SP.   +3 more
europepmc   +1 more source

HDAC4/MybL1/YAP novel signaling axis is required for pancreatic cancer metastasis to the liver. [PDF]

Int J Biol Sci
Edderkaoui M, Elmadbouh OHM, Lim A, Ou Y, Hauptschein D, Guha A, Darwish A, Calsavara VF, Murali R, Bhowmick N, Osipov A, Mathison AJ, Urrutia R, Wang Q, Pandol SJ.   +14 more
europepmc   +1 more source

Histamine N-methyltransferase upregulation, cardiac hypertrophy, and heart failure. [PDF]

Eur Heart J
Zhang J, Jiang H, Liu L, Li X, Hong W, Xu L, Dong Z, Xu Z, Gao J, Sun X, Luo W, Liu J, Song Y, Wang P, Zhang J, Cui Y, Huang L, Zhou X, Zhang Y, Hu K, Yang J, Ge J, Sun A.   +22 more
europepmc   +1 more source

The impactful role of the HDACs in the regulation of gene expression and as targets for disease therapy. [PDF]

Sci Adv
Van Bree BA, Eichner LJ.
europepmc   +1 more source

Histone acetylation and methylation in rare diseases: from molecular mechanisms to clinical presentations. [PDF]

Front Cell Dev Biol
Akman B, Gürsoy S, Gençpınar P, Polat Aİ, Hız AS, Oktay Y, Barakat TS, Özbek U, Erkek-Ozhan S.   +8 more
europepmc   +1 more source